New York, May 13 (IANS) Using pluripotent stem cells, researchers have developed a 3D model of the human lung that could advance our understanding of a variety of respiratory diseases. Also Read - Three Dead, 4 Injured in House Party Shooting in North Carolina
The researchers used the new lung “organoids” — tiny 3D structures that mimic features of a full-sized lung — to generate models of human lung diseases in a lab dish. Also Read - New York to London in 4 Hours On a Plane That Travels Faster Than Speed of Sound? Tantalizing Possibility
By reproducing an organ in a dish, researchers hope to develop better models of human diseases, and find new ways of testing drugs and regenerating damaged tissue. Also Read - 'Another Phase of Greatest Witch Hunt', Says Donald Trump After US Senate Acquits Him in Historic Impeachment Trial
“Researchers have taken up the challenge of creating organoids to help us understand and treat a variety of diseases,” said lead investigator of the study Hans-Willem Snoeck, Professor at Columbia University Medical Centre in the US.
“But we have been tested by our limited ability to create organoids that can replicate key features of human disease,” Snoeck said.
The lung organoids created in Snoeck’s laboratory, however, include branching airway and alveolar structures, similar to human lungs, according to a study published in the journal Nature Cell Biology.
To demonstrate their functionality, the researchers showed that the organoids reacted in much the same way as a real lung does when infected with respiratory syncytial virus (RSV).
Additional experiments revealed that the organoids also responded as a human lung would when carrying a gene mutation linked to pulmonary fibrosis.
Respiratory syncytial virus is a major cause of lower respiratory tract infection in infants and has no vaccine or effective antiviral therapy.
A lung transplant is currently the only cure for idiopathic pulmonary fibrosis, a condition that causes scarring in the lungs.
“Organoids, created with human pluripotent or genome-edited embryonic stem cells, may be the best, and perhaps only, way to gain insight into the pathogenesis of these diseases,” Snoeck said.
This is published unedited from the IANS feed.